Cancer Diagnostic Technology Summit 2021

Multi-Cancer Early Detection: A new paradigm? Sarah Hiom, GRAIL Europe Liquid Biopsy: Detecting Minimal Residual Disease in Breast Cancer Dr. Heather Parsons, Dana Farber Cancer Institute, Boston USA Urinary biomarker tests Dr. Jacqui Stockley, Arquer Diagnostics Detecting nucleic acid biomarkers from liquid biopsies and at the point of care Dr. Sylvain Ladame, Imperial College London, Department of Biomedical Engineering Liquid Biopsy Speakers 8 Continued on next slide